Home Tags Sutro Biopharma

Tag: Sutro Biopharma

SutroVax Closes U.S. $ 110 million Series D financing to Advance...

SutroVax, a next-generation vaccine company, has closed a $110 million Series D preferred stock financing, co-led by new investors RA Capital Management and Janus...

James Panek Joins Sutro Biopharma’s Board of Directors

James P. Panek, an independent consultant since 2011, providing technical and strategic insights to companies around the world, has joined Sutro Biopharma's Board of...
Featured Image: Boston Public Garden; Boston, MA. Courtesy: © 2017 Fotolia. Used with permission.

Encouraging Preliminary Clinical Data in Ongoing Phase I Study for STRO-002...

Initial safety data of STRO-002 shows potent anti-tumor activity in preclinical endometrial cancer patient-derived xenograft (PDX) models were presented at the AACR-NCI-EORTC.FRα is overexpressed...

Sutro Biopharma to Receive Milestone Payment from Merck KGaA for Bispecific...

Sutro Biopharma has achieved a milestone under its collaboration and license agreement with the healthcare division of Merck KGaA, Darmstadt, Germany, in the United...
Board of Directors discussing different issues.

Sutro Biopharma Appoints Former Biogen Idec Executive Connie Matsui as Board...

Sutro Biopharma confirmed that the company has appointed Ms. Connie L. Matsui, retired Executive Vice President of Biogen Idec, as Chair of the company's...

A New Generation of Precisely Engineered CD74-Targeting ADCs Receive Orphan Drug...

The U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for STRO-001 for the treatment of multiple myeloma (MM).In the United States,...